56 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
30
2-Alkoxy-3-(sulfonylarylaminomethylene)-chroman-4-ones as potent and selective inhibitors of ectonucleotidases.
Forman Christian College (A Chartered University)
9
Identification of sulfonic acids as efficient ecto-5'-nucleotidase inhibitors.
Comsats Institute of Information Technology
13
Virtual screening identifies novel sulfonamide inhibitors of ecto-5'-nucleotidase.
Rheinische Friedrich-Wilhelms-Universit£T
31
Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold.
University of Bonn
20
Combinatorial synthesis of anilinoanthraquinone derivatives and evaluation as non-nucleotide-derived P2Y2 receptor antagonists.
University of Bonn
6
Novel Bicyclic Heterocyclic Compounds as CD73 Inhibitors for Treating Cancer.
Smith, Gambrell & Russell
20
Design, synthesis and structure-activity relationship of malonic acid non-nucleoside derivatives as potent CD73 inhibitors.
East China University of Science and Technology
35
Discovery of Novel 5-(Pyridazin-3-yl)pyrimidine-2,4(1H,3H)-dione Derivatives as Potent and Orally Bioavailable Inhibitors Targeting Ecto-5'-nucleotidase.
China Pharmaceutical University
16
Advances in CD73 inhibitors for immunotherapy: Antibodies, synthetic small molecule compounds, and natural compounds.
Chengdu University of Traditional Chinese Medicine
6
Novel Heteroaryl Compounds as CD73 Inhibitors for Treating Cancer.
Smith, Gambrell & Russell
15
Small molecular CD73 inhibitors: Recent progress and future perspectives.
China Medical University
32
Discovery of Small and Bifunctional Molecules Targeting PD-L1/CD73 for Cancer Dual Immunotherapy.
Wenzhou Medical University Lishui Hospital
53
Targeting ecto-5'-nucleotidase: A comprehensive review into small molecule inhibitors and expression modulators.
Federal University of Rio Grande Do Sul
39
Discovery of a Series of Potent, Selective, and Orally Bioavailable Nucleoside Inhibitors of CD73 That Demonstrates
Calithera Biosciences
21
Recent advances in small molecule based cancer immunotherapy.
Southern Medical University
2
Application of marine natural products in drug research.
Weihai Marine Organism & Medical Technology Research Institute
16
Discovery and optimization of betulinic acid derivatives as novel potent CD73 inhibitors.
The Second Military Medical University
24
Structure-Activity Relationship of 3-Methylcytidine-5'-α,β-methylenediphosphates as CD73 Inhibitors.
National Institute of Diabetes and Digestive and Kidney Diseases
24
Structure-activity relationships of pyrimidine nucleotides containing a 5'-α,β-methylene diphosphonate at the P2Y
National Institute of Diabetes and Digestive and Kidney Diseases
32
Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors.
Arcus Biosciences
38
Orally Bioavailable Small-Molecule CD73 Inhibitor (OP-5244) Reverses Immunosuppression through Blockade of Adenosine Production.
Oric Pharmaceuticals
4
Discovery of natural product ellagic acid as a potent CD73 and CD39 dual inhibitor.
Ningxia Medical University
42
Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39.
Arcus Biosciences
86
Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73.
Arcus Biosciences
13
2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes.
University of Bonn
51
Structure-Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5'-Nucleotidase (CD73) Inhibitors.
National Institute of Diabetes and Digestive and Kidney Diseases
7
Lead optimization and biological evaluation of fragment-based cN-II inhibitors.
University of Montpellier
4
CD73 inhibition by purine cytotoxic nucleoside analogue-based diphosphonates.
Claude Bernard University Lyon 1
5
Inhibitors of CD73 May Provide a Treatment for Cancer and Autoimmune Diseases.
Therachem Research Medilab (India)
14
MODULATORS OF A POTASSIUM CHANNEL AND OF TRPV1 CHANNEL AND USES THEREOF
Bsense Bio Therapeutics
55
AROMATIC HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION, AND USE THEREOF
Gt Apeiron Therapeutics
47
PYRAZOLO DERIVATIVES AS HUMAN DIHYDROOROTATE DEHYDROGENASE (HDHODH) INHIBITORS FOR USE AS ANTIVIRALS
Drug Discovery and Clinic
123
INHIBITORS OF THE INTERACTION BETWEEN TRIP8B AND HCN CHANNELS AND USES THEREOF FOR TREATING NEUROLOGICAL DISEASES AND DISORDERS
Northwestern University
3
SALT OF DIHYDROPYRIDO[2,3-D]PYRIMIDINONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF
Nanjing Chia Tai Tianqing Pharmaceutical
92
Cyano-substituted heterocycles with activity as inhibitors of USP30
Mission Therapeutics
121
Pyridine quinoline compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
Vanderbilt University
49
1-(2-(4-CYCLOPROPYL-1H-1,2,3-TRIAZOL-1-YL)ACETYL)-4-HYDROXY-N-(BENZYL)PYRROLIDIN E-2-CARBOXAMIDE DERIVATIVES AS VHL INHIBITORS FOR THE TREATMENT OF ANEMIA AND CANCER
Genentech
822
Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonists
Nimbus Saturn
10
Heteroaryl substituted benzoic acids as RORgammaT inhibitors and uses thereof
Merck Sharp & Dohme
52
Heterocyclic inhibitors of monocarboxylate transporter
The Scripps Research Institute
135
Aminoindane-, aminotetrahydronaphthalene- and aminobenzocyclobutane-derived PRMT5-inhibitors
Ctxt
94
Imidazopyridine derivative and pharmaceutical composition comprising same as active ingredient
TSD Life Sciences
47
Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors
The Medicines Company (Leipzig)
17
Design, synthesis, and X-ray crystal structures of 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors.
Duquesne University
12
4-(1,1-Dioxo-1,4-dihydro-1lambda6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-ones as potent inhibitors of HCV NS5B polymerase.
Anadys Pharmaceuticals